ClinicalTrials.gg
DrugBiological

Palivizumab clinical trials

Also written Synagis.

studies test it
10
open now
0
in phase 3
5
first study started
1999

How each study uses Palivizumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
19 Jun 1998 · SYNAGIS · BLA 103770 (FDA, Drugs@FDA)
European Union
13 Aug 1999 · Synagis · EMEA/H/C/000257 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Palivizumab
6

Brand

Synagis
5

Development codes

ABT-315
1
MEDI-493
1

Studies by the year they started

10 studies that test it; most in 1999 (1)

Studies that test Palivizumab, by start year
YearStudies
19991
20021
20051
20061
20091
20111
20141
20161
20201
20251

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
3
Phase 3
5
Phase 4
1
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 9 · Other 1

MedImmune LLC (3) · AstraZeneca (1) · mAbxience Research S.L. (1) · AbbVie (1) · Hamad Medical Corporation (1) · AbbVie (prior sponsor, Abbott) (1) · Abbott (1) · Fred Hutchinson Cancer Center (1)

Often tested with

Tested in the same studies.

Motavizumab (1) · Ribavirin (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Palivizumab.

Studies

Open first, then newest update. How each study uses Palivizumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 10

As the comparator · 5 — what is tested is compared with Palivizumab

Codes

What other systems call Palivizumab · ClinicalTrials.gg INT006586

  • MeSH (NLM) D000069455PalivizumabConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) DQ448MW7KSPALIVIZUMABConfirmed FDA, NLM, Wikidata
  • RxNorm 194279Confirmed FDA, Wikidata
  • Wikidata Q412765palivizumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C2625PalivizumabOne source FDA
  • DrugBank DB00110One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.